On 5 October, a report by Agora Digitale Transformation revealed that 50 European Parliament members were targeted by deepfake pornography, prompting a cross-party demand for strict enforcement of the EU's AI Act ban on nudifier apps, which takes effect on 2 December.
The UK Health Security Agency announced on 5 October that it is expanding its wastewater surveillance network to monitor both pandemic threats and antimicrobial resistance, a move that aligns with a growing global consensus that the next pandemic is a matter of when, not if.
Cutting ultra-processed food by more than 85% produced moderate to large improvements across three measures of depression in a 20-person pilot study published on 23 September. It was the same week Science devoted a special issue to women's health and researchers pressed ahead with wearable monitoring for chronic pelvic pain.
Robotic surgery is spreading through hospitals worldwide, but fresh evidence and industry reporting on 1 October suggest adoption is now being tested on outcomes, cost and trust rather than novelty.
More than 44,000 people have filed legal objections demanding NHS England block the Palantir-powered Federated Data Platform from handling their medical records, The Guardian reported on 1 October, the same week US insurers put a near $1bn price tag on AI-assisted hospital coding.
The robot industry's own trade press capped a busy September with a top-10 list on 1 October, while a UK evidence review found no clear overall benefit from robotic hip and knee replacement. The two stories point at the same thing: hospital robotics is spreading unevenly.
On 1 October STAT reported that the journal Science devoted a special issue to women's health, arguing that sex-dependent differences in disease are still poorly understood, while a separate study found AI-assisted hospital coding added $942 million in costs.
Medicine shortages in England and Switzerland are colliding with a wider industrial squeeze: on 1 October Micron forecast memory shortages through 2028 and reported an 86.25% gross margin, while ESA warned that Europe's space and defence supply chains depend on semiconductors it does not make.
America's rules for mental health apps built on artificial intelligence remain the least settled part of a widening regulatory fight. A federal health survey redesign published on 1 October removes disability questions that advocates say will erase the very data used to judge such tools.
Eli Lilly has launched a direct-to-consumer model in Australia that routes prescriptions around community pharmacies, STAT reported on 2 October. The move lands as medicine shortages are stretching into 2027 in the UK and pharmacy groups warn supply chains remain fragile.
Blue Cross Blue Shield Association estimates hospitals' use of AI-assisted medical coding added close to $1 billion to its plans' costs between 2023 and 2025, CNBC reported on 1 October, as US health coverage costs are forecast to rise 8.2% per employee in 2027.
At least five Republicans on the Senate Finance Committee are set to leave after the midterms, STAT reported on 1 October, a shake-up that could redirect health policy as digital health and wearable research funding hangs in the balance.
On 1 October, a small UCSF pilot study reported that cutting ultra-processed food by more than 85% was followed by moderate to large improvements in depression scores. Separate reporting the same day showed AI-driven medical coding adding almost $1 billion in health-plan costs.
Neko Health, the body-scanning startup co-founded by Spotify's Daniel Ek, has raised $700 million and is now selling its scans in the United States, TechCrunch reported on 30 September.
US regulators are moving toward a competency-based approval route for generative AI medical devices, according to a Cooley analysis of an FDA proposal, while the agency's September 24 endorsement of a multi-cancer blood test shows how fast the ground is shifting.
Science published a special issue on women's health on Thursday, 1 October, arguing that sex-dependent differences beyond reproduction remain poorly understood. It was the same week that wearable and AI health studies landed with big numbers and small samples.
The journal Science published a special issue on women's health on Thursday, arguing that sex-dependent differences in diseases far beyond reproduction remain poorly understood, while women continue to be under-represented in clinical trials.